Euphorbia sanctae-catharinae
Euphorbia sanctae-catharinae · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Euphorbia sanctae-catharinae is a botanical species that has garnered significant interest within the field of pharmacological research. Recent studies have focused on evaluating its potential biological activities, specifically highlighting its notable antiproliferative properties. To investigate these effects, researchers frequently employ various methods of solvent extraction to isolate its bioactive compounds. These specialized preparations allow for a deeper understanding of how the plant's chemical constituents interact with cellular processes. Consequently, this species represents a promising subject for the development of future therapeutic agents.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Euphorbiaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Not available
Classification
Taxonomy
Euphorbia sanctae-catharinae is a fascinating specimen that belongs to the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. It specifically falls under the order Malpighiales, showcasing its unique evolutionary placement. Furthermore, it is a member of the diverse family Euphorbiaceae. This botanical identity is finalized by its placement within the well-known genus Euphorbia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Euphorbiaceae |
| Genus | Euphorbia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Euphorbia sanctae-catharinae is a resilient plant species primarily found within the Asia-Temperate regions. Its natural distribution stretches across much of Western Asia, showcasing its ability to adapt to diverse environmental conditions. Notably, the species also thrives in the unique landscapes of the Sinai Peninsula. This specific geographic range highlights the plant's specialized role within these distinct ecological niches. Understanding these relationships provides essential insight into the botanical heritage of these arid and temperate zones.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Euphorbia sanctae-catharinae is a self-supporting plant that maintains its own structure without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Euphorbia sanctae-catharinae, an endemic plant species indigenous to the Southern Sinai of Egypt, has proven to be a significant source of bioactive diterpenoids. Recent chemical investigations into this species have successfully isolated several premyrsinane diterpenoids and flavonoids through solvent extraction. These isolated compounds were subsequently subjected to bioassays to evaluate their potential therapeutic properties. The study specifically highlighted the plant's antiproliferative activity against human tumor cell lines, including colon and lung cancers. Notably, one identified compound demonstrated robust antiproliferative effects against A549 lung cancer cells in vitro.
Compounds
Conditions
Euphorbia sanctae-catharinae has demonstrated significant medicinal potential through its ability to treat several diseases in traditional medicine. Research indicates that this endemic Egyptian plant contains compounds with potent anti-proliferative activity. Specifically, it has been shown to treat colon (Caco-2) tumor cell lines in vitro. The plant also effectively treats lung (A549) tumor cell lines, with certain isolated compounds exhibiting robust inhibitory effects. These bioactive properties highlight the therapeutic value of its unique diterpenoid metabolites.
Preparations
Euphorbia sanctae-catharinae was subjected to a solvent extraction process to isolate its chemical constituents. This specific preparation method successfully yielded several premyrsinane diterpenoids alongside various previously reported metabolites. Through this extraction, researchers were able to identify diverse compounds, including three distinct flavonoids. The resulting substances were then chemically characterized using detailed spectroscopic analysis. This methodical solvent extraction provided the necessary materials to conduct subsequent bioassays against specific tumor cell lines.